Cutaneous Gamma-Delta T-cell Lymphoma
Aaron Auerbach, MD, PhD
Key Facts
Terminology
-
T-cell lymphoma of mature γδ cells
-
Separately classified from SPTCL in WHO (2008)
Clinical Issues
-
Hemophagocytic syndrome in 45%
-
Poor prognosis
-
Treated with multiagent chemotherapy
Macroscopic Features
-
Skin nodules with ulceration
Microscopic Pathology
-
3 patterns of disease: Epidermotropic, dermal, and subcutaneous
-
Malignant T cells rim around adipocytes
-
Prominent karyorrhexis/apoptosis and angioinvasion
-
Ancillary Tests
-
Immunohistochemistry: TCRδ1(+), βF1(−), CD56(+), CD4(−), CD8(−), EBER(−), cytotoxic markers (+)
-
T-cell receptor gene rearrangement
Top Differential Diagnoses
-
Subcutaneous panniculitis-like T-cell lymphoma
-
Panniculitis, but not in dermis or epidermis; lacks ulceration; TCRδ1(−), βF1(+)
-
Much better prognosis than CGDTCL
-
-
Peripheral T-cell lymphoma, not otherwise specified
-
Lupus profundus panniculitis
-
Similar inflammation in the subcutis in panniculitic pattern
-
Lobular panniculitis, but contains plasma cells and germinal centers, unlike CGDTCL
-
TERMINOLOGY
Abbreviations
-
Cutaneous gamma-delta T-cell lymphoma (CGDTCL)
Synonyms
-
Subcutaneous panniculitis-like T-cell lymphoma with γδ cells
Definitions
-
T-cell lymphoma arising in the skin, which is composed of cytotoxic γδ T cells
-
Does not include subcutaneous panniculitis-like T-cell lymphoma composed of αβ cells
-
May encompass mucocutaneous γδ cell T-cell lymphoma, but further study is needed
-
-
ETIOLOGY/PATHOGENESIS
Immunosuppression or Dysregulation of T Cells
-
Found in many of the patients
Chronic Antigenic Stimulation
-
Speculative, but possibly involved in pathogenesis
Cell of Origin
-
γδ T cells
-
Involved with mucosal and epithelial immune system function
-
CLINICAL ISSUES
Epidemiology
-
Incidence
-
Rare tumor, < 100 cases reported in literature
-
< 1% of all cutaneous T-cell lymphomas
-
-
-
Age
-
Commonly adults
-
-
Gender
-
No gender preponderance
-
Site
-
Mostly extremities
-
Sometimes mucosal sites, where normal γδ T cells are found
-
Metastasis common
-
Spread to lungs, liver, kidneys, oral mucosa, and brain
-
Usually not in bone marrow, lymph node, or spleen
-
-
Presentation
-
1 or multiple skin lesions
-
Patches or plaques due to epidermal infiltrates
-
Tumors or nodules due to dermal infiltrates
-
± ulcerated epidermis
-
-
-
Hemophagocytic syndrome (HPS) may be present in 45% of cases
-
More often in subcutaneous lesions
-
Related to release of cytotoxic molecules
-
-
Laboratory Tests
-
Cytopenias
-
↑ liver function tests
Treatment
-
Adjuvant therapy
-
Multiagent chemotherapy ± radiotherapy
-
Poor response to allogenic stem cell transplant
-
-
Prognosis
-
Poor prognosis
-
5-year survival: ˜ 11%
-
Subcutaneous disease is a poor prognostic indicator
-
Better prognosis if only disease in dermis or epidermis
-
-
HPS is a poor prognostic indicator
-
MICROSCOPIC PATHOLOGY
Histologic Features
-
3 patterns of disease
-
Epidermotropic
-
Ranges from mild to marked
-
Can mimic mycosis fungoides or pagetoid reticulosis
-
-
Dermal
-
More dermal and epidermal involvement typically present than in subcutaneous panniculitis-like T-cell lymphoma
-
-
Subcutaneous
-
Lobules mostly involved
-
Septae less frequently involved and represents secondary spilling of T cells from lobules
-
Subcutis involvement can appear identical to subcutaneous panniculitis-like T-cell lymphoma of αβ cells, including rimming of fat cells
-
-
-
Often more than 1 pattern of disease in a patient
-
Different patterns of disease in a single biopsy or in different biopsies
-
-
Malignant T cells with nuclear atypia, hyperchromasia
-
Frequent necrosis/apoptosis and vascular invasion
-
Necrosis may be caused by released cytotoxic molecules
-
-
↑ reactive histiocytes
-
Vacuolated foamy cytoplasm from imbibed material/lipid
-
With erythrophagocytosis or cytophagocytosis
-
Cytologic Features
-
Medium to large T cells with coarse, hyperchromatic-staining chromatin, sometimes vesicular nuclei, and variably prominent nucleoli
ANCILLARY TESTS
Immunohistochemistry
-
T-cell antigens (CD2, CD3, CD5, CD7) positive
-
May lose 1 or more T-cell antigens
-
-
Most cases: CD4(−)/CD8(−)
-
Few cases: CD4(−)/CD8(+)
-
-
TCRδ1(+), βF1(−)
-
If TCRδ1 antibody is unavailable, βF1 can be used instead
-
Negative βF1 may serve to assume γδ cell origin
-
-
-
CD56 usually positive, unlike subcutaneous panniculitis-like T-cell lymphoma
Stay updated, free articles. Join our Telegram channel

Full access? Get Clinical Tree

